Latest Insider Transactions at 2seventy Bio, Inc. (TSVT)
This section provides a real-time view of insider transactions for 2seventy Bio, Inc. (TSVT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of 2seventy bio, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of 2seventy bio, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 04
2022
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
467
-0.81%
|
$7,005
$15.41 P/Share
|
|
Jan 07
2022
|
Nick Leschly |
SELL
Open market or private sale
|
Direct |
3,270
-1.71%
|
$75,210
$23.91 P/Share
|
|
Jan 07
2022
|
Philip D Gregory Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,452
-2.3%
|
$33,396
$23.91 P/Share
|
|
Jan 07
2022
|
William D Baird Iii President and CEO |
SELL
Open market or private sale
|
Direct |
896
-1.52%
|
$20,608
$23.91 P/Share
|
|
Dec 07
2021
|
Nicola Heffron Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
257
-0.44%
|
$7,967
$31.06 P/Share
|
|
Nov 11
2021
|
William D Baird Iii President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
56,226
+37.39%
|
-
|
|
Nov 11
2021
|
Sarah Js Glickman |
BUY
Grant, award, or other acquisition
|
Direct |
3,002
+50.0%
|
-
|
|
Nov 11
2021
|
Philip D Gregory Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,009
+38.14%
|
-
|
|
Nov 11
2021
|
Nicola Heffron Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,687
+36.76%
|
-
|
|
Nov 11
2021
|
Ramy Ibrahim |
BUY
Grant, award, or other acquisition
|
Direct |
3,450
+43.36%
|
-
|
|
Nov 11
2021
|
Nick Leschly |
BUY
Grant, award, or other acquisition
|
Direct |
109,616
+35.22%
|
-
|
|
Nov 11
2021
|
Daniel Lynch |
BUY
Grant, award, or other acquisition
|
Direct |
2,803
+33.95%
|
-
|
|
Nov 11
2021
|
Marcela V. Maus |
BUY
Grant, award, or other acquisition
|
Direct |
3,002
+50.0%
|
-
|
|
Nov 11
2021
|
William R. Sellers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,221
+44.24%
|
-
|
|
Nov 11
2021
|
Denice Torres |
BUY
Grant, award, or other acquisition
|
Direct |
2,494
+45.38%
|
-
|
|
Nov 04
2021
|
Bluebird Bio, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Direct |
23,369,088
-100.0%
|
-
|
|
Nov 03
2021
|
Bluebird Bio, Inc. > 10% Shareholder |
BUY
Grant, award, or other acquisition
|
Direct |
23,368,988
+50.0%
|
-
|